Malignant hyperthermia susceptibility revealed by increased serum creatine kinase concentrations during statin treatment.
Krivosic-Horber
R
R
Dépret
T
T
Wagner
J M
JM
Maurage
C A
CA
D000328:Adult; D015415:Biomarkers / Q000097:blood; D003402:Creatine Kinase / Q000097:blood*; D005221:Fatigue / Q000139:chemically induced; D020022:Genetic Predisposition to Disease; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008305:Malignant Hyperthermia / Q000175:diagnosis* / Q000235:genetics; D008875:Middle Aged; D009120:Muscle Cramp / Q000175:diagnosis; D010375:Pedigree
D015415:Biomarkers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D003402:Creatine Kinase